Flores, Yonita M.

HRN: 04-50-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2024
CEFUROXIME 1.5GM (VIAL)
03/09/2024
03/09/2024
IV
1.5
On Call To Or
For Stat Primary LTCS
Waiting Final Action 
03/09/2024
CEFUROXIME 1.5GM (VIAL)
03/09/2024
03/16/2024
IV
1.5g
Q8
S/P PRIMARY LTCS With BTL
Waiting Final Action 
03/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/09/2024
03/16/2024
IV
500mg
Q8
S/P Primary LTCS WITH BTL
Waiting Final Action 
03/11/2024
CEFUROXIME 500MG (TAB)
03/11/2024
03/17/2024
PO
1 Tab
BID
Primary LTCS
Waiting Final Action 
03/11/2024
METRONIDAZOLE 500MG (TAB)
03/11/2024
03/17/2024
PO
1 Tab
TID
SP Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: